ATE78824T1 - Verwendung von nukleosiden zur herstellung eines medikamentes zur behandlung von krankheiten, die durch einen retrovirus oder den hepatitis-b-virus verursacht werden. - Google Patents

Verwendung von nukleosiden zur herstellung eines medikamentes zur behandlung von krankheiten, die durch einen retrovirus oder den hepatitis-b-virus verursacht werden.

Info

Publication number
ATE78824T1
ATE78824T1 AT88900484T AT88900484T ATE78824T1 AT E78824 T1 ATE78824 T1 AT E78824T1 AT 88900484 T AT88900484 T AT 88900484T AT 88900484 T AT88900484 T AT 88900484T AT E78824 T1 ATE78824 T1 AT E78824T1
Authority
AT
Austria
Prior art keywords
carbon atoms
treatment
retrovirus
hepatitis
manufacture
Prior art date
Application number
AT88900484T
Other languages
English (en)
Inventor
Roelf Datema
Kristina Birgitta Gotthammar
Karl Nils Gunnar Johansson
Zsuzsanna Maria Ilona Kovacs
Bjoern Gunnar Lindborg
Goeran Bertil Stening
Bo Fredrik Oeberg
Original Assignee
Medivir Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Medivir Ab filed Critical Medivir Ab
Application granted granted Critical
Publication of ATE78824T1 publication Critical patent/ATE78824T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/06—Pyrimidine radicals

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Molecular Biology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Virology (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
AT88900484T 1986-12-19 1987-12-16 Verwendung von nukleosiden zur herstellung eines medikamentes zur behandlung von krankheiten, die durch einen retrovirus oder den hepatitis-b-virus verursacht werden. ATE78824T1 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
SE8605503A SE8605503D0 (sv) 1986-12-19 1986-12-19 Novel medicinal use
PCT/SE1987/000608 WO1988004662A1 (en) 1986-12-19 1987-12-16 Use of nucleosides for the manufacture of medicament for treatment of diseases caused by retrovirus or hepatitis b virus
EP88900484A EP0294443B1 (de) 1986-12-19 1987-12-16 Verwendung von nukleosiden zur herstellung eines medikamentes zur behandlung von krankheiten, die durch einen retrovirus oder den hepatitis-b-virus verursacht werden

Publications (1)

Publication Number Publication Date
ATE78824T1 true ATE78824T1 (de) 1992-08-15

Family

ID=20366710

Family Applications (1)

Application Number Title Priority Date Filing Date
AT88900484T ATE78824T1 (de) 1986-12-19 1987-12-16 Verwendung von nukleosiden zur herstellung eines medikamentes zur behandlung von krankheiten, die durch einen retrovirus oder den hepatitis-b-virus verursacht werden.

Country Status (9)

Country Link
EP (1) EP0294443B1 (de)
JP (1) JPH01501551A (de)
AT (1) ATE78824T1 (de)
AU (1) AU607965B2 (de)
CA (1) CA1306695C (de)
DE (1) DE3780814T2 (de)
DK (1) DK462688A (de)
SE (1) SE8605503D0 (de)
WO (1) WO1988004662A1 (de)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5212161A (en) * 1988-02-24 1993-05-18 Institut De Recherches Chimiques Et Biologiques Appliquees (I.R.C.E.B.A.) Derivatives of 2'-deoxyuridine substituted in the 5-,3'-or 5'-position by α-aminacyl groups, process for their preparation and drugs in which they are present
SE8802173D0 (sv) * 1988-06-10 1988-06-10 Astra Ab Pyrimidine derivatives
SE8802687D0 (sv) * 1988-07-20 1988-07-20 Astra Ab Nucleoside derivatives
DD293498A5 (de) * 1989-07-20 1991-09-05 Zi Fuer Molekularbiologie Der Adw,De Verfahren zur herstellung eines mittels fuer die behandlung oder prophylaxe von hepatits-infektionen bei mensch und tier
US6001840A (en) * 1990-03-06 1999-12-14 Southern Research Institute Methods of treatment of viral infections using carbocyclic deoxyguanosine analogs
GB9012899D0 (en) * 1990-06-09 1990-08-01 Wellcome Found Anti-hbv pyrimidine nucleoside
GB9125271D0 (en) * 1991-11-27 1992-01-29 Wellcome Found Anti-hbv pyrimidine nucleoside
EP0788507B1 (de) * 1994-10-24 2004-12-15 Genencor International, Inc. L-pyranosyl-nukleoside
US5559101A (en) * 1994-10-24 1996-09-24 Genencor International, Inc. L-ribofuranosyl nucleosides
US7244717B2 (en) * 2001-08-24 2007-07-17 Koronis Pharmaceuticals, Incorporated Mutagenic nucleoside analogs for the treatment of viral disease
WO2003053360A2 (en) * 2001-12-20 2003-07-03 Pharmassett Ltd. Treatment of ebv and khsv infection and associated abnormal cellular proliferation
EP2264044B1 (de) 2008-03-12 2014-08-20 Japan Advanced Institute of Science and Technology Verfahren für den nachweis von methylcytosin anhand einer lichtempfindlichen sonde

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3328388A (en) * 1964-09-02 1967-06-27 Merck & Co Inc Arabinofuranosyl pyrimidines and methods of preparing same
DE1620185C3 (de) * 1966-03-02 1982-01-14 Robugen Gmbh Pharmazeutische Fabrik Esslingen A.N., 7300 Esslingen 5-Äthyl- und 5-Propyl-2'-deoxyuridin, Verfahren zur Herstellung dieser Verbindungen und diese Verbindungen enthaltende Arzneimittel
AT281862B (de) * 1968-07-11 1970-06-10 Robugen Gmbh Verfahren zur Herstellung von neuen 2'-Desoxyuridinen
GB1601020A (en) * 1978-04-24 1981-10-21 Stichting Grega Vzw 2'-deoxy-5 (2-halogenovinyl)-uridines
US4267171A (en) * 1979-07-02 1981-05-12 The Regents Of The University Of California C-5 Substituted cytosine nucleosides
US4247544A (en) * 1979-07-02 1981-01-27 The Regents Of The University Of California C-5 Substituted uracil nucleosides
JPS5639019A (en) * 1979-09-05 1981-04-14 Yamasa Shoyu Co Ltd Antiviral agent
GB2060604B (en) * 1979-10-03 1983-11-23 Univ Birmingham And Stichting E15-(2-halogenovinyl)-2'-deoxycytidines
JPS5687599A (en) * 1979-12-19 1981-07-16 Yamasa Shoyu Co Ltd E 55 22halogenovinyl arabinofuranosyluracil and its preparation
DE3045375A1 (de) * 1980-12-02 1982-07-01 Robugen Gmbh Pharmazeutische Fabrik Esslingen A.N., 7300 Esslingen Neue substituierte pyrimidin-nukleoside mit antiviraler wirkung, verfahren zu deren herstellung und daraus zubereitete arzneiformen
FR2531962B1 (fr) * 1982-08-17 1986-11-14 Sandoz Sa Nouveaux derives de la desoxyuridine, leur preparation et leur utilisation comme medicaments
JPS5979658A (ja) * 1982-10-28 1984-05-08 Fujitsu Ltd 複合交換機
AP11A (en) * 1985-03-16 1987-12-22 The Wellcome Foundation Ltd Antiviral nucleosides.
EP0258412A1 (de) * 1986-02-20 1988-03-09 GREER, Sheldon B. Zubereitung und verfahren zur behandlung von aids und verwandten krankheiten

Also Published As

Publication number Publication date
DE3780814T2 (de) 1992-12-10
DK462688D0 (da) 1988-08-18
AU1083488A (en) 1988-07-15
WO1988004662A1 (en) 1988-06-30
EP0294443A1 (de) 1988-12-14
SE8605503D0 (sv) 1986-12-19
DE3780814D1 (de) 1992-09-03
CA1306695C (en) 1992-08-25
JPH01501551A (ja) 1989-06-01
DK462688A (da) 1988-08-18
EP0294443B1 (de) 1992-07-29
AU607965B2 (en) 1991-03-21

Similar Documents

Publication Publication Date Title
DE3855099D1 (de) Nucleoside zur Verwendung für die Therapie
ATE50256T1 (de) Hypoglycemische thiazolidinedione.
ATE78824T1 (de) Verwendung von nukleosiden zur herstellung eines medikamentes zur behandlung von krankheiten, die durch einen retrovirus oder den hepatitis-b-virus verursacht werden.
ATE83659T1 (de) Verwendung von indolon-derivaten zur herstellung von arzneimitteln zur behandlung des parkinsonismus.
DE3855113D1 (de) Verwendung von Buspiron zur Herstellung eines pharmazeutischen Präparats zur Behandlung der Alkoholsucht
KR900701282A (ko) 심장 또는 뇌의 허혈성 질환의 치료, 예방제
ATE257378T1 (de) Phenylacetylglutamin, phenylacetylisoglutamin, und/oder phenylacetat zur behandlung von neoplastischen erkrankungen
DE3174807D1 (en) Pharmaceutical composition
DE69326395D1 (de) Spirooxathiolan-quinuclidin-Derivat zur Behandlung des Sjögren-Syndroms
KR890001580A (ko) B형 간염 바이러스에 의해 유발되는 염증 질환을 치료하는 이중가닥 rna를 함유하는 약물
KR950701638A (ko) 푸린 동족체의 항비루스성 포스폰산 유도체(Antiviral phosphonic acid derivatives of purine analogues)
DE69501359D1 (de) Verwendung von Phosphatdiestern zur Behandlung von Erkrankungen der Retina
KR900009647A (ko) 아데노신 유도체, 그들의 제법 및 사용방법
MD940152A (ro) Compoziţie farmaceutică pentru tratarea infecţiilor şi bolilor, provocate de virusul hepatitei V (HBV)
KR890008136A (ko) 항균성 9-데옥소-9a-알릴 및 프로파길-9a-아자-9a-호모에리트로 마이신 A 유도체
DK0410749T3 (da) Anthocyanidiner til behandling af ophthalmiske sygdomme
DE3767308D1 (de) Verwendung von sulfonamidderivaten zur herstellung eines antivirusmittels.
GR3001793T3 (en) Polyprenyl alcohol-containing injections and use thereof
KR880001596A (ko) 디하이드로피리딘 화합물-함유 뇌기능이상 치료제
DE69428112D1 (de) Verwendung von thymosin zur behandlung von hepatitis c bei patienten, die auf interferongaben nicht ansprechen
ATE24834T1 (de) Verwendung von beta-(1-adamantyl)-alpha, alphadimethylethylamin zur herstellung eines arzneimittels zur behandlung von otitis externa bei hunden.
ATE83381T1 (de) Verwendung von rekombiniertem menschlichem alpha- interferon zur herstellung eines arzneimittels zur behandlung des aids-virus.
KR890017363A (ko) 스트로빌루린 유도체, 이들의 제법 및 용도
ATE121623T1 (de) Verwendung von quinazolinen zur herstellung eines arzneimittels zur behandlung und vorbeugung von arrhythmie.
ATE22009T1 (de) Verwendung von alpha, alphadialkyladamantylethylaminen zur behandlung von masernvirus.

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
REN Ceased due to non-payment of the annual fee